Swiss Luxury Stock News

Accelleron Industries (SWX:ACLN) has been added to the FTSE All-World Index in USD terms, a change that can matter for investors who track how large global funds allocate fresh capital. Accelleron Industries has seen brisk trading around the FTSE All-World Index news, with a 1-day share price return of 4.98% on CHF77.0 and a 7-day share price return of 9.61%, even though the 90-day share price return declined 7.73%, while the 3-year total shareholder return of 246.08% points to powerful...

Central banks are hinting at more rate hikes, borrowing costs are climbing, and long-term yields are reshaping how investors think about risk. That mix can hurt some areas of the market, yet it can also open doors for certain global banks and broker-dealers tied into capital markets, trading, and underwriting. This article walks through 3 stocks from our screener that appear positively exposed to the current news backdrop. The three stocks highlighted next are only a starter set from this...

Lonza Group expansion in Bend, Oregon Lonza Group (SWX:LONN) has announced a large-scale spray-drying facility in Bend, Oregon, aimed at reinforcing its US manufacturing footprint and supporting small molecule, biologics, and mRNA programs. The project centers on a commercial spray-drying hub equipped with two PSD-4 units and supporting solvent infrastructure. It is designed to offer full spray-dried dispersion capacity across clinical and commercial stages. Management expects completion in...

Georg Fischer was removed from the FTSE All-World Index (USD) on 19 September 2026, reducing its presence in a widely tracked global benchmark. The exclusion may add pressure to Georg Fischer’s shift toward higher-margin flow solutions, as passive index demand and visibility both decline. This article examines how Georg Fischer’s investment narrative interacts with its FTSE All-World exclusion and what that may mean for investors. Broaden your options by checking Georg Fischer against a...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

Novartis (SWX:NOVN) has drawn fresh attention after regulators in Europe issued a positive opinion for expanding Cosentyx into polymyalgia rheumatica, bringing a new potential indication for this franchise to investors’ attention. The Cosentyx update lands at a time when Novartis has seen mixed momentum, with the share price down about 8.9% over the past month and 5.9% over 90 days, yet still showing a 7.0% year-to-date share price return and a 21.7% total shareholder return over one year...

Partners Group Holding has opened a new office in Stockholm, Sweden, which will host investment professionals and serve as a regional base to support its private infrastructure, real estate, and private credit activities across the Nordics, within a wider European network that includes Zug, London, Paris, and other hubs. The move links Partners Group Holding's existing Nordic investment track record, including data centers and renewable energy platforms, with on the ground coverage that can...

Avolta AG has issued €350 million of senior 5.25% notes due March 31, 2032, placed under Regulation S and aimed at non U.S. institutional investors, with admission to the Official List of The International Stock Exchange expected. The group is also testing a blockchain based direct settlement payment model that bypasses traditional card networks, which could influence transaction costs, data ownership and the economics of Avolta’s airport retail operations over time. We will now look at how...

Zuger Kantonalbank (SWX:ZUGER) has appointed Alexander Hunziker as Chief Investment Officer, promoting him from his previous role as deputy CIO. The leadership change may influence how the bank approaches investment processes and product design. Investors have been pricing in a stronger story around Zuger Kantonalbank for some time. The share price is at CHF10,800 after a 20.81% year-to-date share price return and a 27.67% total shareholder return over the past year. The 50.14% three-year and...

ABB has attracted fresh attention after recent share price moves, with market interest underpinned by robust order intake in electrification, utilities and data center demand, alongside progress in building to grid and direct current power technologies. The combination of strong backlog support and emerging projects such as ABB’s work on building to grid systems and the Ferrari Hypersail partnership highlights how the company’s power technology pipeline is shaping expectations around future...

Aevis Victoria (SWX:AEVS) drew fresh attention after reporting half year 2026 results, with sales of CHF 639.1 million, revenue of CHF 547.02 million and net income of CHF 5.42 million. Aevis Victoria’s latest figures have landed alongside a sharp swing in the share price, with a 7-day share price return of 24.9% and a 30-day move of 23.44% pushing the stock to CHF15.8. This comes even though the 3-year total shareholder return is down 15.06%, while the 5-year total shareholder return of...

Logitech International (SWX:LOGN) just pushed through amendments to its Articles of Incorporation at the 8 September 2026 AGM, giving investors fresh governance details to weigh alongside recent share performance. Set against a 1-month share price return of 8.26% and a year-to-date gain of 4.50% to CHF83.06, Logitech International’s recent AGM rule changes and fresh MX Keypad and gaming partnership announcements come as momentum has softened, with the 1-year total shareholder return declining...

Ams OSRAM has moved its optical force sensor technology into robotic hands, positioning these components as an alternative to incumbent piezoelectric solutions and highlighting their ability to keep force readings stable while relying on the company’s established automotive qualification standards. This expansion into robotics points to Ams OSRAM seeking new industrial end markets beyond its traditional automotive base. This development could influence product mix, capital allocation, and...

Sandoz Group (SWX:SDZ) just packed two key updates into a single week, pairing a global emicizumab biosimilar collaboration with mAbxience and fresh Health Canada approval for Sandoz Semaglutide in type 2 diabetes. The stock has been volatile in recent weeks, with a 7.4% decline over the past 30 days even as the year-to-date share price return is 19.9% and the 1-year total shareholder return is 45.7%. This suggests momentum has been building as Sandoz Group rolls out new biosimilar deals,...

ABB has had a powerful run over the past few years. This makes the current share price of CHF 80.02 a simple question for investors: are the cash flows that the business can generate over time enough to justify where the stock trades today? Over the past 5 years, ABB has delivered a 190.0% share price return, which puts serious weight on whether that performance matches the value of its future cash flows. Recent work on direct current technology and building energy management, including...

Galderma Group has delivered a 10.1% return over the past year, and the move raises a simple question for anyone watching the stock today. Is the current share price adequately explained by the cash flows investors can reasonably expect the business to generate over time? The 10.1% gain over the last 12 months puts real weight on whether Galderma Group’s recent share price now fully bakes in its cash flow profile. Fresh study data on Restylane Volyme in China may support expectations for...

Adecco Group has rolled out Salesforce's Agentforce Coworker across more than 40 countries after pilots in the UK and France. The deployment extends agentic AI tools into the workflows of 27,000 employees and draws on more than 2,500,000 agent candidate interactions to support global sales and recruitment processes. Akkodis, part of Adecco Group, has shifted regional leadership in Germany and Austria to Giles Guidicelli. The move pairs a prepared management transition with a focus on AI,...

Sensirion Holding’s new biogas analyzer and why it matters for investors Sensirion Holding (SWX:SENS) has just introduced the DynamiQ-X BG2300, a micro gas chromatograph aimed at fast online biogas and biomethane analysis. This development puts fresh attention on its role in energy and environmental technology. The launch of the DynamiQ-X BG2300 lands at a time when Sensirion Holding’s CHF78.0 share price has produced a 25.81% year-to-date share price return. However, the 5-year total...

Temenos (SWX:TEMN) is back in focus after a recent share price move that left the stock down about 8% over the past month while still showing a positive total return over the past year. The recent pullback leaves Temenos trading at CHF67.4, with a 30 day share price return that is down 7.8%, a 1 year total shareholder return of 5.6%, and a 3 year total shareholder return of 10.2%. This suggests that momentum has cooled rather than vanished. Compare Temenos's recent pullback with other hand...

Aevis Victoria stock closed at CHF15.80 after a strong run in recent weeks, yet the real story sits in the gap between that price and the portfolio value sitting underneath it. Book value per share, measured as net asset value, is CHF26.75, which leaves the equity trading at more than a 50% discount to what the underlying hospitals, hotels and ventures are marked at. H1 2026 earnings did not blow the doors off on profit, but they reinforced that net asset value is edging higher while...

Adecco Group (SWX:ADEN) is rolling out Agentforce Coworker, Salesforce's Claude powered AI assistant, to 27,000 staff across more than 40 countries following pilot programs in the UK and France. Recent trading has reflected increasing interest in Adecco Group, with the share price at CHF24.46 and a 90-day share price return of 60.5% in addition to a 1-year total shareholder return of 23.34%, even though the 3 and 5-year total shareholder returns remain in decline. Scan how Adecco Group’s AI...

Novartis (SWX:NOVN) agreed to acquire full global rights to Sironax's brain delivery platform for $125 million upfront. The platform is designed to help transport therapies across the blood brain barrier for neurological and rare brain disorders. Sironax keeps certain rights to develop its own pipeline on the technology while Novartis gains broad access to the core platform. Novartis securing Sironax's brain delivery platform matters, but investors should weigh it alongside other factors for...

Helvetia Baloise Holding came into today quietly ahead of the pack. The stock had already logged gains of about 7.6% over the past week and roughly 8.6% over three months, so expectations were not low. The headline from this earnings season is not the share price move. It is the strain between a very rich trailing P/E of 40.9x and a story built on future earnings power rather than current cash flow. Management highlights high forecast profit growth and an ambitious dividend roadmap. Investors...

Sandoz Group issued a €500 million bond with a 4.835% coupon and 12-year maturity, aiming to use the proceeds for general corporate purposes including refinancing existing debt and keeping its average interest rate on gross borrowings below 4%. The new bond extends Sandoz Group’s debt maturity profile to 2038 and supports its goal of preserving investment grade ratings from Moody’s and S&P, which can influence funding flexibility for ongoing biosimilar manufacturing investments. We will now...